Book Online or Call 1-855-SAUSALITO
Sign In \| Register \| About Sausalito \| Contact Us
Sausalito, CA September 01, 2020 1:41pm 7-Day Forecast \| Traffic

- Apartments

Merck & Co (NY: MRK )

81.42 USD +0.13 (+0.17%)

Streaming Delayed Price Updated: 12:51 PM EST, Jan 20, 2022 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	5,869,100
Open	80.73
Bid (Size)	81.42 (8)
Ask (Size)	81.43 (5)
Prev. Close	81.29
Today's Range	80.52 - 81.86
52wk Range	15.32 - 91.40
Shares Outstanding	2,531,374,696
Dividend Yield	3.19%

Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News

Gastrointestinal Cancer Treatment Trials Driven by Rising Incidences of Colorectal Cancer

Today 8:31 EST

Results From Pivotal Phase 3 KEYNOTE-775/Study 309 Trial of KEYTRUDA® (pembrolizumab) Plus LENVIMA® (lenvatinib) in Advanced Endometrial Carcinoma Published in the New England Journal of Medicine

Today 6:50 EST

Phase 3 Results of KEYNOTE-775/Study 309 Trial KEYTRUDA Plus LENVIMA in Advanced Endometrial Carcinoma Published in New England Journal of Medicine

Performance

YTD	+5.93%	+5.93%
1 Month	+6.56%	+6.56%
3 Month	+0.44%	+0.44%
6 Month	+6.59%	+6.59%
1 Year	-2.12%	-2.12%

More News

Frank Clyburn to Leave Merck

Today 6:45 EST

Merck Scientists Launch Research Award to Support Rising Chemists of Color

January 19, 2022

SPYV, MRK, WMT, MMM: Large Inflows Detected at ETF

Today 10:56 EST

Casi Pharma-Partnered BioInvent's Lead Cancer Program Gets FDA Orphan Drug Tag

Today 8:50 EST

Merck’s KEYTRUDA® (pembrolizumab) Significantly Improved Overall Survival (OS) Versus Placebo in Certain Patients With Advanced Hepatocellular Carcinoma (HCC) Previously Treated With Sorafenib

January 18, 2022

South Africa study shows boosters failed to block omicron, bolstering case for face masks, distancing and hand washing

Today 10:48 EST

We need a decisive pivot on COVID-19: Double down on treatments for those at high risk instead of boosters and tests for everyone

Today 10:26 EST

The Daily Biotech Pulse: Novavax COVID Shot Authorized In Australia, Zymeworks Restructures, Orphan Drug Designation For Marker's Pancreatic Cancer Drug

Today 8:28 EST

Merck and Ridgeback Announce Supply Agreement with UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine

January 18, 2022

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Search Hotels in Sausalito

Find A Business

or Browse Listings

Merck & Co (NY: MRK )

Price and Volume

Top News

Performance

More News